{
    "Trade/Device Name(s)": [
        "Diazyme Fibrinogen Assay",
        "Diazyme Fibrinogen Calibrator Set",
        "Diazyme Fibrinogen Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K143470",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993482"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIS",
        "GFX",
        "GIL"
    ],
    "Summary Letter Date": "January 15, 2016",
    "Summary Letter Received Date": "January 19, 2016",
    "Submission Date": "January 15, 2016",
    "Regulation Number(s)": [
        "21CFR864.7340"
    ],
    "Regulation Name(s)": [
        "Fibrinogen determination system"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Modular P analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Fibrinogen Assay and associated calibrator and control sets for quantitative fibrinogen measurement in citrated human plasma using immunoturbidimetric method on Roche Modular P analyzer",
    "Indications for Use Summary": "Diazyme Fibrinogen Assay quantitatively determines fibrinogen in citrated human plasma; calibrator set is for assay calibration and control set is for quality control, all for in vitro diagnostic use only.",
    "fda_folder": "Hematology"
}